Fadogia agrestis is one of the most hyped testosterone ingredients online right now, and it is not in our formula. That is a deliberate choice, not an oversight. It has no published human studies, the evidence is animal-only from a narrow set of research, and there are some safety questions in those animal models. We run one rule, no study, no entry, and Fadogia is the cleanest example of it we have.
Where the hype came from
Fadogia got popular the way a lot of ingredients do now: a well-known science podcaster mentioned taking it, usually paired with tongkat ali, and demand followed the mention. That is a real driver of the category, and to be fair the same podcast raised the general level of ingredient literacy among men. But a personal protocol is not evidence, and even the people who take Fadogia tend to say out loud that the human data is not there yet.
What the evidence actually is
Here is the state of it. The studies on Fadogia are in rodents, from a limited body of work, and some of them raise concerns about effects on the testes at higher doses. There are no published randomized controlled trials in humans establishing either that it works or what a safe long-term dose would be. For an ingredient people take daily for months, that is a large blank space. Compare that to tongkat ali, which has a 2022 meta-analysis of human trials, and the gap is obvious.
Why leaving it out is the point
It would be easy to add Fadogia. It rides a trend, it would let us put a buzzy name on the label, and plenty of competitors have done exactly that. We did not, because the whole promise of the brand is that every ingredient earns its place with human evidence at a studied dose. An ingredient we excluded proves that rule better than any ingredient we included, because it shows the rule has teeth even when following it costs us a trend. That is the version of trust you cannot fake.
If the evidence changes
None of this is a permanent verdict on Fadogia. If well-designed human trials arrive and establish a safe, effective dose, we will read them like anything else. The rule is not anti-Fadogia. It is pro-evidence. Right now the evidence is not there, so neither are we.
Straight answers
Is Fadogia agrestis safe?
There are no human safety studies, and some animal models raise concerns at higher doses. Without human data, we do not consider that a safe basis for a daily product.
Does Fadogia raise testosterone?
The rodent research is suggestive, but there are no published human trials showing it works in people. Suggestive is not proven.
Why does Huberman take it if it is unproven?
A personal protocol from anyone, however credible, is not the same as published human evidence. We covered the wider stack in the Huberman stack piece.
The Daily includes ten actives with human evidence at studied doses, and pointedly leaves out the hyped ones that lack it. See what made the cut.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.